financetom
Market
financetom
/
Market
/
Positive on TCS for long-term, says Ambareesh Baliga
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Positive on TCS for long-term, says Ambareesh Baliga
Jul 11, 2018 7:53 AM

Positive on Tata Consultancy Services (TCS) after the information technology major posted Rs 7,340 crore consolidated net profit for the first quarter of fiscal 2018-19, said Ambareesh Baliga, independent market expert.

In an interview to CNBC-TV18, Baliga said if one can hold TCS shares for the next one and a half to two years, Rs 1,900-2,000 can easily give you Rs 2,600-2,700 if not more.

"It's a clear no-brainer. Just pick up TCS and forget it. Pick up now and if you have, hold on," Baliga said.

Speaking about the fertiliser stocks, Baliga said, "Normally, during the monsoons, you start seeing fertiliser stocks starting to move. That is one of the reasons why you are seeing some sort of a move in Rashtriya Chemicals & Fertilizers (RCF). However, there is nothing really major which I have heard because of which it should start moving."

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-S&P 500, Nasdaq fall as investors dial back bets on Fed rate cuts in 2025
US STOCKS-S&P 500, Nasdaq fall as investors dial back bets on Fed rate cuts in 2025
Jan 13, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click/ or type LIVE/ in a news window.) * Moderna ( MRNA ) slides after cutting 2025 sales forecast * Chip stocks fall as US tightens grip on AI chip flows * Health insurers rise after US proposes 2026 payment rates * Nasdaq hits more than one-month low...
Top Midday Stories: Moderna Shares Fall After 2025 Revenue Guidance Cut; Cleveland-Cliffs Reportedly Teams Up With Nucor in Potential Bid for US Steel
Top Midday Stories: Moderna Shares Fall After 2025 Revenue Guidance Cut; Cleveland-Cliffs Reportedly Teams Up With Nucor in Potential Bid for US Steel
Jan 13, 2025
11:54 AM EST, 01/13/2025 (MT Newswires) -- The three major US stock indexes were mixed around midday Monday, the first trading day after the release of better-than-expected employment numbers that meant lower chances of future rate cuts. In corporate news, Moderna ( MRNA ) shares fell over 20% in recent trading after the company said it now expects 2025 revenue...
US STOCKS-S&P 500, Nasdaq fall as investors scale back bets on Fed rate cuts in 2025
US STOCKS-S&P 500, Nasdaq fall as investors scale back bets on Fed rate cuts in 2025
Jan 13, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click/ or type LIVE/ in a news window.) * Moderna ( MRNA ) slides after cutting 2025 sales forecast * Chip stocks fall as US tightens grip on AI chip flows * Health insurers rise after US proposes 2026 payment rates * Nasdaq hits more than one-month low...
Why BioNTech (BNTX) Shares Are Volatile Today
Why BioNTech (BNTX) Shares Are Volatile Today
Jan 13, 2025
Shares of BioNTech SE ( BNTX ) – ADR fell 5.7% to $115.84 on Monday, part of a broader decline in vaccine stocks triggered by Moderna's updated revenue guidance for 2025, which fell below analyst expectations. What To Know: Moderna, whose stock plunged 23% Monday morning, projected revenues of $1.5 billion to $2.5 billion, well short of the $2.95 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved